vs

Side-by-side financial comparison of CBL & ASSOCIATES PROPERTIES INC (CBL) and Oncology Institute, Inc. (TOI). Click either name above to swap in a different company.

CBL & ASSOCIATES PROPERTIES INC is the larger business by last-quarter revenue ($156.4M vs $142.0M, roughly 1.1× Oncology Institute, Inc.). CBL & ASSOCIATES PROPERTIES INC runs the higher net margin — 31.3% vs -5.3%, a 36.6% gap on every dollar of revenue. On growth, Oncology Institute, Inc. posted the faster year-over-year revenue change (41.6% vs 18.8%). Over the past eight quarters, Oncology Institute, Inc.'s revenue compounded faster (22.5% CAGR vs 10.1%).

CBL & Associates Properties, Inc. is an American real estate investment trust that invests in shopping centers and shopping malls, primarily in the Southeastern and Midwestern United States. The company is organized in Delaware with its headquarters in Chattanooga, Tennessee. Its largest market is Chattanooga, Tennessee. The company's name is based on the initials of its founder, Charles B. Lebovitz.

Oncology Institute, Inc. is a specialized healthcare enterprise focused on delivering patient-centric, evidence-based oncology care services, including advanced treatment regimens, clinical trial access, and supportive care programs. It primarily operates across the United States, serving patients with diverse cancer diagnoses and partnering with care teams to improve treatment outcomes.

CBL vs TOI — Head-to-Head

Bigger by revenue
CBL
CBL
1.1× larger
CBL
$156.4M
$142.0M
TOI
Growing faster (revenue YoY)
TOI
TOI
+22.8% gap
TOI
41.6%
18.8%
CBL
Higher net margin
CBL
CBL
36.6% more per $
CBL
31.3%
-5.3%
TOI
Faster 2-yr revenue CAGR
TOI
TOI
Annualised
TOI
22.5%
10.1%
CBL

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CBL
CBL
TOI
TOI
Revenue
$156.4M
$142.0M
Net Profit
$49.0M
$-7.5M
Gross Margin
Operating Margin
-4.9%
Net Margin
31.3%
-5.3%
Revenue YoY
18.8%
41.6%
Net Profit YoY
29.0%
43.0%
EPS (diluted)
$1.61
$-0.04

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CBL
CBL
TOI
TOI
Q4 25
$156.4M
$142.0M
Q3 25
$139.3M
$136.6M
Q2 25
$140.9M
$119.8M
Q1 25
$141.8M
$104.4M
Q4 24
$131.7M
$100.3M
Q3 24
$125.1M
$99.9M
Q2 24
$129.7M
$98.6M
Q1 24
$129.1M
$94.7M
Net Profit
CBL
CBL
TOI
TOI
Q4 25
$49.0M
$-7.5M
Q3 25
$75.4M
$-16.5M
Q2 25
$2.8M
$-17.0M
Q1 25
$8.8M
$-19.6M
Q4 24
$38.0M
$-13.2M
Q3 24
$16.2M
$-16.1M
Q2 24
$4.7M
$-15.5M
Q1 24
$50.0K
$-19.9M
Operating Margin
CBL
CBL
TOI
TOI
Q4 25
-4.9%
Q3 25
-5.9%
Q2 25
-9.4%
Q1 25
-9.5%
Q4 24
-11.9%
Q3 24
-13.9%
Q2 24
-16.6%
Q1 24
-19.0%
Net Margin
CBL
CBL
TOI
TOI
Q4 25
31.3%
-5.3%
Q3 25
54.2%
-12.1%
Q2 25
2.0%
-14.2%
Q1 25
6.2%
-18.8%
Q4 24
28.8%
-13.1%
Q3 24
12.9%
-16.1%
Q2 24
3.7%
-15.7%
Q1 24
0.0%
-21.0%
EPS (diluted)
CBL
CBL
TOI
TOI
Q4 25
$1.61
$-0.04
Q3 25
$2.38
$-0.14
Q2 25
$0.08
$-0.15
Q1 25
$0.27
$-0.21
Q4 24
$1.22
$-0.14
Q3 24
$0.52
$-0.18
Q2 24
$0.14
$-0.17
Q1 24
$-0.01
$-0.22

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CBL
CBL
TOI
TOI
Cash + ST InvestmentsLiquidity on hand
$42.3M
Total DebtLower is stronger
$2.2B
Stockholders' EquityBook value
$374.9M
$-15.7M
Total Assets
$2.7B
$164.7M
Debt / EquityLower = less leverage
5.79×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CBL
CBL
TOI
TOI
Q4 25
$42.3M
Q3 25
$52.6M
Q2 25
$100.3M
Q1 25
$100.3M
Q4 24
$40.8M
Q3 24
$65.1M
Q2 24
$57.7M
$9.9M
Q1 24
$57.7M
$29.8M
Total Debt
CBL
CBL
TOI
TOI
Q4 25
$2.2B
Q3 25
$2.2B
Q2 25
$2.1B
Q1 25
$2.2B
Q4 24
$2.2B
Q3 24
$1.8B
Q2 24
$1.9B
Q1 24
$1.9B
Stockholders' Equity
CBL
CBL
TOI
TOI
Q4 25
$374.9M
$-15.7M
Q3 25
$351.4M
$-12.3M
Q2 25
$289.4M
$-9.0M
Q1 25
$295.0M
$5.1M
Q4 24
$323.5M
$3.6M
Q3 24
$308.3M
$15.5M
Q2 24
$308.8M
$29.2M
Q1 24
$324.2M
$41.3M
Total Assets
CBL
CBL
TOI
TOI
Q4 25
$2.7B
$164.7M
Q3 25
$2.7B
$163.6M
Q2 25
$2.6B
$159.8M
Q1 25
$2.6B
$164.0M
Q4 24
$2.7B
$172.7M
Q3 24
$2.2B
$179.2M
Q2 24
$2.3B
$179.6M
Q1 24
$2.3B
$204.5M
Debt / Equity
CBL
CBL
TOI
TOI
Q4 25
5.79×
Q3 25
6.21×
Q2 25
7.39×
Q1 25
7.29×
Q4 24
6.84×
Q3 24
5.76×
Q2 24
6.00×
Q1 24
5.74×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CBL
CBL
TOI
TOI
Operating Cash FlowLast quarter
$249.7M
$3.2M
Free Cash FlowOCF − Capex
$2.2M
FCF MarginFCF / Revenue
1.5%
Capex IntensityCapex / Revenue
0.7%
Cash ConversionOCF / Net Profit
5.10×
TTM Free Cash FlowTrailing 4 quarters
$-27.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CBL
CBL
TOI
TOI
Q4 25
$249.7M
$3.2M
Q3 25
$69.6M
$-12.6M
Q2 25
$68.3M
$-10.2M
Q1 25
$31.7M
$-5.0M
Q4 24
$202.2M
$4.2M
Q3 24
$61.1M
$819.0K
Q2 24
$64.2M
$-15.7M
Q1 24
$30.7M
$-15.9M
Free Cash Flow
CBL
CBL
TOI
TOI
Q4 25
$2.2M
Q3 25
$-13.2M
Q2 25
$-11.4M
Q1 25
$-5.3M
Q4 24
$2.4M
Q3 24
$46.0M
$417.0K
Q2 24
$54.8M
$-17.5M
Q1 24
$24.7M
$-16.5M
FCF Margin
CBL
CBL
TOI
TOI
Q4 25
1.5%
Q3 25
-9.7%
Q2 25
-9.5%
Q1 25
-5.1%
Q4 24
2.4%
Q3 24
36.8%
0.4%
Q2 24
42.2%
-17.7%
Q1 24
19.1%
-17.4%
Capex Intensity
CBL
CBL
TOI
TOI
Q4 25
0.7%
Q3 25
0.4%
Q2 25
1.0%
Q1 25
0.3%
Q4 24
1.8%
Q3 24
12.1%
0.4%
Q2 24
7.3%
1.9%
Q1 24
4.7%
0.6%
Cash Conversion
CBL
CBL
TOI
TOI
Q4 25
5.10×
Q3 25
0.92×
Q2 25
24.74×
Q1 25
3.60×
Q4 24
5.32×
Q3 24
3.77×
Q2 24
13.54×
Q1 24
614.76×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CBL
CBL

Segment breakdown not available.

TOI
TOI

Other$82.1M58%
Fee For Service$36.3M26%
Capitated Revenue$23.6M17%

Related Comparisons